CrystalGenomics Inc. | Mutual Funds
Mutual Funds that own CrystalGenomics Inc.
Vanguard Total International Stock Index Fund
456,855
1.14%
3,802
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
336,030
0.85%
0
0.01%
09/05/2018
Vanguard Developed Markets Index Fund
179,574
0.45%
1,566
0%
07/31/2018
Pacific Horizon Investment Trust Plc
91,628
0.23%
0
0.64%
10/31/2017
Government Pension Fund - Global (The)
82,926
0.21%
61,719
0%
12/31/2017
Vanguard FTSE All World (ex-US) Small Cap
79,810
0.2%
632
0.02%
07/31/2018
Mirae Asset TIGER Health Care ETF
64,670
0.16%
17,055
0.78%
04/30/2018
iShares Plc - Core MSCI Emerging Markets IMI UCITS ETF
55,317
0.14%
0
0.01%
09/05/2018
Vanguard Pacific Stock Index Fund
35,647
0.09%
309
0.01%
07/31/2018
Schwab International Small Cap Equity ETF
30,568
0.08%
0
0.02%
09/06/2018
| Address |
5/F, Tower A, Korea Bio Park
Seongnam GY 13488
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.crystalgenomics.com |
| Updated |
09/14/2018 |
| CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company operates through following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services. |
